About this trial
The goal of this clinical trial is to learn about breast cancer patients. The main questions it aims to answer are:
* Does Aerobic Dance During Chemotherapy Improve Cognitive Function in Breast Cancer Patients? * Does the efficacy of aerobic dance differ from fast walking of equal intensity? Recruited patients will be randomly assigned to three groups: (1) aerobic dance group, (2) fast walking group, and (3) usual care group.
The aerobic dance and fast-walking groups participated in supervised exercise lasting 50 minutes thrice a week for 12 weeks.
The goal of this study's findings is to develop practical strategies for managing breast cancer-related cognitive impairment.
Eligibility criteria
Qualifiers
18-65 years old
Newly diagnosed, histologically confirmed, resected stage I-IIIa BC
Scheduled for chemotherapy with Epirubicin+ Cyclophosphamide (EC) regimen
Presence of objective cognitive decline
Disqualifiers
Regular exercise habits (exercise at moderate intensity for 30 minutes a day, 3 days a week, for at least 3 months.),
Motor dysfunction
Alzheimer's disease
Vascular dementia
Trial design
Treatments tested in this trial
- Aerobic dance
- Fast-walking